cting on sex and gender in medical innovation is good for business.
Vijayasingham L., Bischof E., Ateghang-Awankem B., Rumaney M., Otmani Del Barrio M., Cheah PY., Ter-Meulen AS., Tannenbaum C., Morgan R., Wolfe J., Gender and Covid-19 Research Agenda Setting Initiative .
Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits